IBL HealthCare Limited (PSX:IBLHL)
Pakistan · Delayed Price · Currency is PKR 40.44
-0.19 (-0.47%)
At close: Nov 6, 2026
IBL HealthCare Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 4,607 | 4,607 | 4,322 | 3,603 | 4,028 | 3,651 | |
Revenue Growth | 5.57% | 6.59% | 19.96% | -10.54% | 10.32% | 21.55% |
Cost of Revenue | 2,974 | 2,965 | 2,879 | 2,654 | 2,691 | 2,400 |
Gross Profit | 1,634 | 1,642 | 1,444 | 949.32 | 1,336 | 1,251 |
Selling, General & Admin | 1,234 | 1,198 | 999.3 | 795.96 | 726.7 | 680.77 |
Other Operating Expenses | -12.84 | - | - | - | - | - |
Operating Expenses | 1,233 | 1,209 | 999.3 | 806.06 | 726.7 | 680.77 |
Operating Income | 400.83 | 433.1 | 444.59 | 143.25 | 609.68 | 570.69 |
Interest Expense | -33.63 | -41.83 | -58.29 | -65.43 | -64.14 | -25.7 |
Currency Exchange Gain (Loss) | 5.76 | 5.76 | -12.51 | 27.18 | -109.57 | -72.83 |
Other Non Operating Income (Expenses) | 4.22 | 4.22 | 3.3 | 3.7 | 22.86 | 9.81 |
EBT Excluding Unusual Items | 377.18 | 401.26 | 377.09 | 108.7 | 458.82 | 481.97 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.01 | 1.92 |
Asset Writedown | - | - | - | - | - | -0.62 |
Pretax Income | 377.18 | 401.26 | 377.09 | 108.7 | 458.83 | 483.27 |
Income Tax Expense | 162.42 | 180.85 | 168.72 | 101.15 | 149.87 | 180.41 |
Net Income | 214.76 | 220.4 | 208.37 | 7.56 | 308.96 | 302.86 |
Net Income to Common | 214.76 | 220.4 | 208.37 | 7.56 | 308.96 | 302.86 |
Net Income Growth | -1.57% | 5.77% | 2658.05% | -97.56% | 2.02% | 0.79% |
Shares Outstanding (Basic) | 99 | 99 | 99 | 99 | 99 | 99 |
Shares Outstanding (Diluted) | 99 | 99 | 99 | 99 | 99 | 99 |
Shares Change | -0.05% | - | - | - | - | 0.00% |
EPS (Basic) | 2.18 | 2.24 | 2.11 | 0.08 | 3.14 | 3.07 |
EPS (Diluted) | 2.18 | 2.24 | 2.11 | 0.08 | 3.14 | 3.07 |
EPS Growth | -1.52% | 5.77% | 2658.06% | -97.56% | 2.02% | 0.79% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 857.14 | 653.31 | -278.81 | 566.44 | 24.34 | 55.56 |
Free Cash Flow Per Share | 8.69 | 6.63 | -2.83 | 5.75 | 0.25 | 0.56 |
Dividend Per Share | - | - | - | - | - | 0.659 |
Dividend Growth | - | - | - | - | - | 19.98% |
Gross Margin | 35.46% | 35.64% | 33.40% | 26.35% | 33.18% | 34.28% |
Operating Margin | 8.70% | 9.40% | 10.29% | 3.98% | 15.14% | 15.63% |
Profit Margin | 4.66% | 4.78% | 4.82% | 0.21% | 7.67% | 8.29% |
Free Cash Flow Margin | 18.60% | 14.18% | -6.45% | 15.72% | 0.60% | 1.52% |
EBITDA | 406.59 | 438.75 | 447.81 | 146.34 | 612.95 | 575.98 |
EBITDA Margin | 8.82% | 9.52% | 10.36% | 4.06% | 15.22% | 15.78% |
D&A For EBITDA | 5.76 | 5.65 | 3.22 | 3.09 | 3.28 | 5.29 |
EBIT | 400.83 | 433.1 | 444.59 | 143.25 | 609.68 | 570.69 |
EBIT Margin | 8.70% | 9.40% | 10.29% | 3.98% | 15.14% | 15.63% |
Effective Tax Rate | 43.06% | 45.07% | 44.74% | 93.05% | 32.66% | 37.33% |